Get the app!
Back to Trades
Grant4

Apellis Pharmaceuticals, Inc.

APLS

Total Value
$1.5M

Company Information

Ticker Symbol
APLS
CIK
0001492422

Insider Information

Role
Chief Research and Development
Location
WALTHAM, MA

Filing Details

Filing Date
Sep 2, 2025
Transaction Date
Aug 26, 2025
Accession Number
0001127602-25-021056
Form Type
4

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.